Bronchitol EU Marketing Authorisation Update
Release Date: 20/12/2010 12:00am
Pharmaxis today announced that the review of the European Marketing Application will not conclude as previously advised during Q4 2010.
At the Committee for Medicinal Products for Human Use (CHMP) meeting last week, it was agreed, that Bronchitol would be the subject of an oral explanation at the January meeting. Therefore, the review is now expected to conclude during Q1 2011.
Categories: News and Media